Last Updated: September 23, 2026

Hikma Intl Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HIKMA INTL PHARMS

HIKMA INTL PHARMS has forty approved drugs.

There are five US patents protecting HIKMA INTL PHARMS drugs.

Summary for Hikma Intl Pharms

US Patents:	5
Tradenames:	33
Ingredients:	32
NDAs:	40

Drugs and US Patents for Hikma Intl Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma Intl Pharms	NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	022276-003	Apr 7, 2016	AP	RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Hikma Intl Pharms	MEFLOQUINE HYDROCHLORIDE	mefloquine hydrochloride	TABLET;ORAL	077699-001	Apr 21, 2010		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Hikma Intl Pharms	NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	022276-002	Apr 7, 2016	AP	RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Hikma Intl Pharms	DIPHENHYDRAMINE HYDROCHLORIDE	diphenhydramine hydrochloride	CAPSULE;ORAL	083567-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Hikma Intl Pharms	CAPTOPRIL	captopril	TABLET;ORAL	074505-003	Feb 13, 1996	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for HIKMA INTL PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	0.6 mg	➤ Subscribe	2016-06-10

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.